Lowe HC - Search Results

1

c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury.

Luo X, Cai H, Ni J, Bhindi R, Lowe HC, Chesterman CN, Khachigian LM. Luo X, et al. Among authors: lowe hc. Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1836-42. doi: 10.1161/ATVBAHA.109.189753. Epub 2009 Jul 10. Arterioscler Thromb Vasc Biol. 2009. PMID: 19592465

2

Rat models of myocardial infarction. Pathogenetic insights and clinical relevance.

Bhindi R, Witting PK, McMahon AC, Khachigian LM, Lowe HC. Bhindi R, et al. Among authors: lowe hc. Thromb Haemost. 2006 Nov;96(5):602-10. Thromb Haemost. 2006. PMID: 17080217 Review.

3

Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.

Bhindi R, Fahmy RG, McMahon AC, Khachigian LM, Lowe HC. Bhindi R, et al. Among authors: lowe hc. J Pathol. 2012 Jun;227(2):157-64. doi: 10.1002/path.2991. Epub 2012 Feb 17. J Pathol. 2012. PMID: 22344601

4

DNAzymes targeting the transcription factor Egr-1 reduce myocardial infarct size following ischemia-reperfusion in rats.

Bhindi R, Khachigian LM, Lowe HC. Bhindi R, et al. Among authors: lowe hc. J Thromb Haemost. 2006 Jul;4(7):1479-83. doi: 10.1111/j.1538-7836.2006.02022.x. J Thromb Haemost. 2006. PMID: 16839341 Free article.

5

DNAzymes and cardiovascular disease.

Benson VL, Khachigian LM, Lowe HC. Benson VL, et al. Among authors: lowe hc. Br J Pharmacol. 2008 Jun;154(4):741-8. doi: 10.1038/bjp.2008.145. Epub 2008 May 5. Br J Pharmacol. 2008. PMID: 18454170 Free PMC article. Review.

6

Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries.

Lowe HC, Chesterman CN, Khachigian LM. Lowe HC, et al. Thromb Haemost. 2002 Jan;87(1):134-40. Thromb Haemost. 2002. PMID: 11848443

7

Novel and emerging therapies in cardiology and haematology.

Pimanda JE, Lowe HC, Hogg PJ, Chesterman CN, Khachigian LM. Pimanda JE, et al. Among authors: lowe hc. Curr Drug Targets Cardiovasc Haematol Disord. 2003 Jun;3(2):101-23. doi: 10.2174/1568006033481465. Curr Drug Targets Cardiovasc Haematol Disord. 2003. PMID: 12769638 Review.

8

Animal models of vulnerable plaque. Clinical context and current status.

Lowe HC, Jang IK, Khachigian LM. Lowe HC, et al. Thromb Haemost. 2003 Nov;90(5):774-80. doi: 10.1160/TH03-06-0374. Thromb Haemost. 2003. PMID: 14597970 Review.

9

Fibroblast growth factor 2 and the transcription factor Egr-1 localise to endothelial cell microvascular channels in human coronary artery occlusion.

Bhindi R, Brieger D, Ishii H, Di Girolamo N, Kumar RK, Khachigian LM, Lowe HC. Bhindi R, et al. Among authors: lowe hc. Thromb Haemost. 2005 Jan;93(1):172-4. Thromb Haemost. 2005. PMID: 15875316 No abstract available.

10

Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, Saravolac EG, Sun LQ, Khachigian LM. Bhindi R, et al. Among authors: lowe hc. Am J Pathol. 2007 Oct;171(4):1079-88. doi: 10.2353/ajpath.2007.070120. Epub 2007 Aug 23. Am J Pathol. 2007. PMID: 17717148 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters